Advanced Filters
noise

Continuous Glucose Monitoring Clinical Trials

A listing of Continuous Glucose Monitoring medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 44 clinical trials

Non-Nutritive Sweetener Consumption and Glucose Homeostasis in Older Adults With Prediabetes

Animal and observational research in humans suggest that specific types of non-nutritive sweeteners (NNS) may impair glycemic control. However, whether NNS consumption impacts glucose homeostasis in middle-aged/older adults with prediabetes is unknown, and potential mechanisms by which this could occur have yet to be identified. The overall objective of this …

40 years of age All Phase N/A
J JUAN FRANCISCO MERINO TORRES, Medicine

Transition to Hospital Discharge in Insulinized Patients With Type 2 Diabetes Mellitus

This clinical study explores whether adding technological tools during hospital discharge can help people with type 2 diabetes who are starting insulin therapy achieve better treatment adherence and blood glucose control once they return home. The discharge transition period includes both the final days of hospitalization and the first weeks …

18 - 70 years of age All Phase N/A
M Mary E Vajravelu, MD

Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes

The goal of this study is to pilot test features of a new smartphone app and to gather feedback related to wearing a continuous glucose monitor (CGM) and a Fitbit device, as well as to obtain input on health behavior-focused messages delivered through the app. The study will enroll English-speaking …

16 - 24 years of age All Phase N/A

First Trimester Prediction of Gestational Diabetes Mellitus by Continuous Glucose Monitoring.

Gestational diabetes mellitus (GDM) is the most common complication of pregnancy, with an incidence rate of 10-15% [1]. Common risk factors for GDM are increased maternal age and weight and as a consequence of women delaying childbirth and increasing incidence of obesity, there is a corresponding increase in the rate …

18 years of age Female Phase N/A
A Alexander Martinez

Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring

This study is to see if the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) will help prolong the length of time people with diabetes maintain adherence to glucagon-like peptide 1 (GLP-1/GIP) agonists.

18 years of age All Phase N/A
S Shehzad Topiwala, MD

Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)

"To evaluate the use of the Dexcom CGM System when used according to approved commercial labeling during standard clinical use and its impact on intended users in a real-world setting"

2 years of age All Phase N/A
V Valentina Stanley, BS

Continuous Glucose Monitoring in Infants

The purpose of this study is to employ continuous glucose monitoring to measure glucose profiles in newborn infants.

- 2 years of age All Phase N/A
K Kevin Cowart, PharmD, MPH

Pharmacist-led Continuous Glucose Monitoring

This is a pilot study. The goal of this prospective cohort study is to determine impact of pharmacist-led continuous glucose monitoring on glycemic control and health behavior change in people with type 2 diabetes. The main questions it aims to answer are: to assess change in hemoglobin A1c in people …

18 years of age All Phase N/A
I Ida Voss, MD

Continuous Glucose Monitoring (CGM) After Kidney Transplantation

This study examines glucose levels measured by continuous glucose monitoring (CGM) in the immediate period following kidney transplantation among recipients with diabetes, without diabetes, and with pre-diabetes. The primary objective is to analyse differences in mean sensor glucose between these three groups. CGMs are applied to participants within 72 hours …

18 years of age All Phase N/A
K Katherine Desjardins

Identification of Dysglycemia With Continuous Glucose Monitoring to Assess Clinical Evolution in Cystic Fibrosis

Cystic fibrosis (CF)-related diabetes (CFRD) is the most important emerging complication after pulmonary complications. This specific form of diabetes is associated with an increased morbidity and mortality. CFRD prevalence at the age of 10 is 10% and reaches 40 to 50% in adulthood, while a similar percentage is afflicted with …

18 years of age All Phase N/A

Simplify language using AI